159 related articles for article (PubMed ID: 2186525)
1. Analyses of development of insulitogenic T lymphocytes in NOD mice by transplantation of bone marrow, thymus, and pancreas.
Ida T; Yasumizu R; Ohnishi Y; Honxue F; Oyaizu N; Than S; Sugiura K; Inaba MM; Kuzuya H; Makino S
Transplantation; 1990 May; 49(5):976-82. PubMed ID: 2186525
[TBL] [Abstract][Full Text] [Related]
2. Induction of insulitis in athymic (nude) mice. The effect of NOD thymus and pancreas transplantation.
Georgiou HM; Mandel TE
Diabetes; 1995 Jan; 44(1):49-59. PubMed ID: 7813814
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal allogeneic bone marrow transplantation between NOD mice and diabetes-nonsusceptible mice associated with transfer and prevention of autoimmune diabetes.
LaFace DM; Peck AB
Diabetes; 1989 Jul; 38(7):894-901. PubMed ID: 2661286
[TBL] [Abstract][Full Text] [Related]
4. Transplantation analysis of B cell destruction in (NOD x CBA)F1 mouse bone marrow chimeras.
Serreze DV; Leiter EH; Shultz LD
Diabetologia; 1990 Feb; 33(2):84-92. PubMed ID: 2109714
[TBL] [Abstract][Full Text] [Related]
5. Expression of genetically determined diabetes and insulitis in the nonobese diabetic (NOD) mouse at the level of bone marrow-derived cells. Transfer of diabetes and insulitis to nondiabetic (NOD X B10) F1 mice with bone marrow cells from NOD mice.
Wicker LS; Miller BJ; Chai A; Terada M; Mullen Y
J Exp Med; 1988 Jun; 167(6):1801-10. PubMed ID: 3290380
[TBL] [Abstract][Full Text] [Related]
6. Development of insulin-dependent diabetes mellitus in [(NOD + BALB/c) --> NOD] mixed allogeneic bone marrow chimeras.
Takao F; Yasumizu R; Than S; Ohnishi-Inoue Y; Sigiura K; Inaba M; Ikehara S
Immunobiology; 1995 Nov; 194(4-5):376-89. PubMed ID: 8749231
[TBL] [Abstract][Full Text] [Related]
7. Patterns of hemopoietic reconstitution in nonobese diabetic mice: dichotomy of allogeneic resistance versus competitive advantage of disease-resistant marrow.
Kaufman CL; Li H; Ildstad ST
J Immunol; 1997 Mar; 158(5):2435-42. PubMed ID: 9036994
[TBL] [Abstract][Full Text] [Related]
8. Grafts of supplementary thymuses injected with allogeneic pancreatic islets protect nonobese diabetic mice against diabetes.
Salaün J; Simmenauer N; Belo P; Coutinho A; Le Douarin NM
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):874-7. PubMed ID: 11792835
[TBL] [Abstract][Full Text] [Related]
9. Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation.
Ikehara S; Ohtsuki H; Good RA; Asamoto H; Nakamura T; Sekita K; Muso E; Tochino Y; Ida T; Kuzuya H
Proc Natl Acad Sci U S A; 1985 Nov; 82(22):7743-7. PubMed ID: 3906651
[TBL] [Abstract][Full Text] [Related]
10. Development of diabetogenic T cells from NOD/Lt marrow is blocked when an allo-H-2 haplotype is expressed on cells of hemopoietic origin, but not on thymic epithelium.
Serreze DV; Leiter EH
J Immunol; 1991 Aug; 147(4):1222-9. PubMed ID: 1869820
[TBL] [Abstract][Full Text] [Related]
11. Reconstitution of (BALB/c x B6)F1 normal mice with stem cells and thymus from nonobese diabetic mice results in autoimmune insulitis of the normal hosts' pancreases.
Stein PH; Rees MA; Singer A
Transplantation; 1992 Jun; 53(6):1347-52. PubMed ID: 1604490
[TBL] [Abstract][Full Text] [Related]
12. Absence of insulitis and overt diabetes in athymic nude mice with NOD genetic background.
Makino S; Harada M; Kishimoto Y; Hayashi Y
Jikken Dobutsu; 1986 Oct; 35(4):495-8. PubMed ID: 3542537
[TBL] [Abstract][Full Text] [Related]
13. The NOD mouse as a model of type I diabetes.
Tochino Y
Crit Rev Immunol; 1987; 8(1):49-81. PubMed ID: 2961513
[TBL] [Abstract][Full Text] [Related]
14. Treatment of systemic and organ-specific autoimmune disease in mice by allogeneic bone marrow transplantation.
Ikehara S; Nakamura T; Sekita K; Muso E; Yasumizu R; Ohtsuki H; Hamashima Y; Good RA
Prog Clin Biol Res; 1987; 229():131-46. PubMed ID: 3299389
[TBL] [Abstract][Full Text] [Related]
15. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
[TBL] [Abstract][Full Text] [Related]
16. Rationale for bone marrow transplantation in the treatment of autoimmune diseases.
Ikehara S; Good RA; Nakamura T; Sekita K; Inoue S; Oo MM; Muso E; Ogawa K; Hamashima Y
Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2483-7. PubMed ID: 3887403
[TBL] [Abstract][Full Text] [Related]
17. The effect of bone marrow and thymus chimerism between non-obese diabetic (NOD) and NOD-E transgenic mice, on the expression and prevention of diabetes.
Parish NM; Chandler P; Quartey-Papafio R; Simpson E; Cooke A
Eur J Immunol; 1993 Oct; 23(10):2667-75. PubMed ID: 8405065
[TBL] [Abstract][Full Text] [Related]
18. Treatment of type 1 diabetes mellitus in non-obese diabetic mice by transplantation of allogeneic bone marrow and pancreatic tissue.
Yasumizu R; Sugiura K; Iwai H; Inaba M; Makino S; Ida T; Imura H; Hamashima Y; Good RA; Ikehara S
Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6555-7. PubMed ID: 3114751
[TBL] [Abstract][Full Text] [Related]
19. A study on the timing of immunologic priming in autoimmune insulitis in NOD mice.
Kai N; Motojima K; Shiogama T; Terada M; Tamaki S; Tsunoda T; Kanematsu T
Transplant Proc; 1992 Jun; 24(3):1040-1. PubMed ID: 1376511
[No Abstract] [Full Text] [Related]
20. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice.
Nishimoto H; Kikutani H; Yamamura K; Kishimoto T
Nature; 1987 Jul 30-Aug 5; 328(6129):432-4. PubMed ID: 3302721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
